Zdrowie i gospodarka · 17/06/2026

FDA Classifies Radiological Machine Learning-Based Imaging Software as Class II Device

The FDA has classified the radiological machine learning-based quantitative imaging software with a predetermined change control plan as a Class II device, which will provide a reasonable assurance of safety and effectiveness, and potentially reduce regulatory burdens, thereby enhancing patients' access to innovative devices.